SEC Form 4 · accession 0001140361-15-043744
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald R Melillo Jr.
Officer — President, Sales Services
Period of report
Nov 25, 2015
Accepted (ET)
Dec 4, 2015 · 9:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 25, 2015 | S | 4,262 | $0.78 | D | 132,686 | D | |
| Common StockF2 | Nov 30, 2015 | S | 765 | $0.80 | D | 131,921 | D | |
| Common StockF2 | Dec 1, 2015 | S | 1,748 | $0.77 | D | 130,173 | D | |
| Common StockF1 | holding | — | — | — | 136,948 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF3 | $6.63 | holding | — | — | — | — | Jan 30, 2017 | Common Stock | 21,478 | 21,478 | D |
| Stock Appreciation RightsF4 | $5.44 | holding | — | — | — | — | Apr 4, 2018 | Common Stock | 30,364 | 51,842 | D |
| Stock Appreciation RightsF5 | $5.13 | holding | — | — | — | — | Feb 25, 2019 | Common Stock | 57,107 | 108,949 | D |
Explanation of responses
- F1Includes 122,484 restricted shares of common stock. The outstanding shares of restricted stock will vest upon the closing of the proposed sale of the Company's CSO segment, if the closing occurs on or before February 28, 2016. If such sale does not close on or before February 28, 2016, Mr. Melillo will forfeit all of his outstanding shares of restricted stock.
- F2Sales of common stock on the open market.
- F3Exercisable.
- F4Stock appreciation rights that are two-thirds vested. The remaining one-third will vest and become exercisable upon the closing of the proposed sale of the Company's CSO segment, if the closing occurs on or before February 28, 2016. If such sale does not close on or before February 28, 2016, Mr. Melillo will forfeit all of his outstanding SARs.
- F5Stock appreciation rights that are one-third vested. The remaining two-thirds will vest and become exercisable upon the closing of the proposed sale of the Company's CSO segment, if the closing occurs on or before February 28, 2016. If such sale does not close on or before February 28, 2016, Mr. Melillo will forfeit all of his outstanding SARs.
Remarks
Mr. Melillo's last day of employment with PDI was December 1, 2015.